08Jun
FDA Signals a Deliberative Approach to Cannabis at Public Hearing
While it was ostensibly convened to gather scientific input from stakeholders on how to appropriately regulate cannabis-infused products, the Food and Drug Administration (FDA) also used the May 31, 2019 public hearing as a platform to issue a call...
By:
Wilson Sonsini Goodrich & Rosati
Related
Alex Acosta’s resignation from the Labor Secretary post signaled a quick blow to a key member of Pr...
Read More >
In August 2013, Arkansas enacted a statute intended to regulate employers’ ability to access social...
Read More >
With the start of a new year—and a new decade—employers in San Francisco, California, Waterloo, Io...
Read More >
In this episode of Phorensically Speaking, Jonathan Marks looks at corporate governance approaches t...
Read More >
On January 16, 2020, the United States Department of Labor (DOL) issued its Final Rule on Joint Empl...
Read More >
There has been an important milestone in the search for more legal certainty in gun-jumping cases: O...
Read More >